This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The University of Texas System. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Chieko Mineo: Innovator in Atherosclerosis Treatment
Introduction
Chieko Mineo is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of medical research, particularly in the treatment of atherosclerosis. With a total of 2 patents, her work focuses on innovative methods to improve cardiovascular health.
Latest Patents
Chieko Mineo's latest patents include groundbreaking inventions aimed at treating atherosclerosis. One of her patents, titled "Reelin antibodies for treatment of atherosclerosis," provides methods and compositions for treating this condition. The invention utilizes therapeutic compounds to reduce Reelin in the circulation of a subject, thereby decreasing the adhesion of leukocytes to the vascular wall. This approach not only addresses the underlying causes of atherosclerosis but also offers new avenues for treatment. Another patent, "Methods and compositions for treatment of atherosclerosis," echoes similar themes, emphasizing the reduction of leukocyte adhesion to the vascular wall.
Career Highlights
Chieko Mineo is affiliated with the University of Texas System, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential impact on public health, particularly in combating cardiovascular diseases.
Collaborations
Chieko collaborates with esteemed colleagues, including Linzhang Huang and Xunde Xian, who contribute to her research endeavors. These collaborations enhance the depth and breadth of her work, fostering a rich environment for innovation.
Conclusion
Chieko Mineo stands out as a dedicated inventor in the medical field, with her patents paving the way for advancements in the treatment of atherosclerosis. Her contributions reflect a commitment to improving health outcomes through innovative research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
